Status:
COMPLETED
A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
Lead Sponsor:
GE Healthcare
Collaborating Sponsors:
i3 Statprobe
Conditions:
Parkinsonian Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Patients come to their doctor showing possible symptoms of a movement disorder. It is possible that these symptoms may get worse over time. There is more than one disease that can cause such symptoms....
Eligibility Criteria
Inclusion
- Subjects with clinically uncertain Parkinsonian Syndromes or monosymptomatic, atypical or incomplete presentation of tremor, rigidity, bradykinesia or postural instability.
- Onset of clinical manifestations within the last 5 years
Exclusion
- Differential diagnosis between Parkinsons´s Disease and Progressive Supranuclear Palsy or between Parkinson´s Disease and Multiple System Atrophy
- Subjects with an established/certain movement disorder clinical diagnosis
- Presence of known causes of tremor
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
273 Patients enrolled
Trial Details
Trial ID
NCT00382967
Start Date
October 1 2006
End Date
January 1 2011
Last Update
September 3 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
GE Healthcare
Princeton, New Jersey, United States, 08540
2
GE Healthcare
Vélizy-Villacoublay, France, 78457